Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd., Appeal No. 2023-1977 (Fed. Cir. Apr. 8, 2025)
In our Case of the Week, the Federal Circuit affirmed that defendant Alkem’s proposed generic antibiotic did not...more
4/15/2025
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Claim Construction ,
Generic Drugs ,
Hatch-Waxman ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prior Art ,
Writ of Mandamus
Actavis Labs. FL, Inc. v. United States, Appeal No. 2023-1320 (Fed. Cir. Mar. 21, 2025)
Our Case of the Week, in the words of its author, Circuit Judge Stark, “is not actually a patent case. It is, instead, a tax case.” In...more
3/25/2025
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Claim Construction ,
Court of Federal Claims ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Inter Partes Review (IPR) Proceeding ,
International Trade Commission (ITC) ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
USPTO
In re: Xencor, Inc., Appeal No. 2024-1870 (Fed. Cir. Mar. 13, 2025)
Our case of the week is an appeal from a decision of the Appeals Review Panel of the Patent Trial and Appeal Board, concerning Xencor’s patent application...more
3/18/2025
/ Appeals ,
Claim Construction ,
Federal Court Litigation ,
Intellectual Property Protection ,
Life Sciences ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Reissue Patents ,
Written Descriptions
Trudell Medical International Inc. v. D R Burton Healthcare, LLC, Appeal Nos. 2023-1777, -1779 (Fed. Cir. Feb. 7, 2025)
This week’s Case of the Week presents a cautionary tale for litigators to be sure they’ve timely...more
Steuben Foods, Inc. v. Shibuya Hoppman Corp., Appeal No. 2023-1790 (Fed. Cir. Jan. 24, 2025)
In its only precedential patent decision this week, the Federal Circuit addressed an “anachronistic exception, long mentioned but...more
1/29/2025
/ Appeals ,
Claim Construction ,
Damages ,
Doctrine of Equivalents ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
JMOL ,
Patent Act ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Summary Judgment
Honeywell International Inc. v. 3G Licensing, S.A., Appeal Nos. 2023-1354, -1384, -1407 (Fed. Cir. Jan. 2, 2025)
In this week’s Case of the Week, the Federal Circuit reversed an inter partes review finding of the Patent...more
CloudofChange, LLC v. NCR Corp., Appeal No. 2023-1111 (Fed. Cir. Dec. 18, 2024)
In our Case of the Week, the Federal Circuit addressed the question of divided infringement in the context of system claims. In its...more
12/24/2024
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Claim Construction ,
Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Inter Partes Review (IPR) Proceeding ,
Motivation to Combine ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Remand ,
Reversal ,
Technology ,
Vacated
UTTO Inc. v. Metrotech Corp., Appeal No. 23-1435 (Fed. Cir. Oct. 18, 2024)
In its only precedential patent decision this week, the Court analyzed the extent to which claim construction is appropriate on a motion to...more
Vascular Solutions LLC v. Medtronic, Inc., Appeal No. 24-1398 (Fed. Cir. Sept. 16, 2024)
In our Case of the Week, the Federal Circuit evaluated certain heavily litigated claims directed to guide catheters. The patents...more
Sanho Corp. v. Kaijet Technology International Limited Inc., Appeal No. 2023-1336 (Fed. Cir. July 31, 2024)
In our Case of the Week, the Federal Circuit held that the private but non-confidential sale of thousands of...more
8/7/2024
/ Appeals ,
Claim Construction ,
Final Written Decisions ,
Inventions ,
Inventors ,
Obviousness ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Public Disclosure
Zyxel Comms. Corp. v. UNM Rainforest Innovations, Appeal Nos. 2022-2220, -2250 (Fed. Cir. July 22, 2024)
Our Case of the Week provided new guidance on amendment proceedings under the Patent Trial and Appeal Board’s 2019...more
SnapRays v. Lighting Defense Group, Appeal No. 2023-1184 (Fed. Cir. May 2, 2024)
Our Case of the Week deals with an issue the Court has not addressed recently: the question of declaratory judgment jurisdiction....more
5/7/2024
/ Anticipation ,
Appeals ,
Claim Construction ,
Damages ,
Declaratory Judgments ,
Inter Partes Review (IPR) Proceeding ,
Mootness ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Ownership ,
Patent Trial and Appeal Board ,
Patents ,
Personal Jurisdiction ,
Printed Matter Doctrine ,
Remand ,
Vacated
Janssen Pharms., Inc. et al. v. Teva Pharm. USA, Inc. et al., Appeal Nos. 2022-1258, -1307 (Fed. Cir. April 1, 2024)
In this week’s Case of the Week, the Federal Circuit vacated-in-part a district court’s bench trial...more
4/9/2024
/ Abstract Ideas ,
Appeals ,
Claim Construction ,
Janssen Pharmaceuticals ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Remand ,
Teva Pharmaceuticals
Pfizer Inc. v. Sanofi Pasteur Inc., Appeal Nos. 2019-1871, -1873, -1875, -1876, -2224 (Fed. Cir. Mar. 5, 2024)
This week’s Case of the Week mostly resolves an appeal filed five years ago, following decisions from the...more
3/12/2024
/ Alice/Mayo ,
Appeals ,
Claim Construction ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Remand ,
Reversal
Freshub, Inc. v. Amazon.com, Inc., Appeal Nos. 2022-1391, -1425 (Fed. Cir. Feb. 26, 2024)
In the Court’s only precedential patent opinion this week, the Court affirmed a jury finding that use of Amazon’s “Alexa” products...more
Promptu Systems Corporation v. Comcast Corporation, Appeal No. 2022-1939 (Fed. Cir. Feb. 16, 2024)
Our Case of the Week focuses on a district court’s claim construction rulings in a patent case brought against Comcast...more
Univ. of South Florida Bd. of Trustees v. United States, Appeal No. 2022-2248 (Fed. Cir. Feb. 9, 2024)
In this week’s Case of the Week, the Federal Circuit examined the scope of a provision of the Bayh-Dole Act of 1980 (35...more
2/14/2024
/ Appeals ,
Bayh-Dole Act ,
Claim Construction ,
Federal Funding ,
Final Written Decisions ,
Inter Partes Review (IPR) Proceeding ,
Inventions ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Post-Grant Review ,
Prior Art
Pacific Biosciences of California, Inc. v. Personal Genomics Taiwan, Inc., Appeal Nos. 2022-1410, -1554 (Fed. Cir. January 9, 2024)
In this week’s Case of the Week, the Federal Circuit affirmed two inter partes review...more
K-Fee System GmbH v. Nespresso USA, Inc., Appeal No. 2022-2042 (Fed. Cir. Dec. 26, 2023)
In an appeal from a district court judgment of noninfringement, the Federal Circuit reversed the underlying claim construction...more
ParkerVision, Inc. v. Vidal, Appeal No. 2022-1548 (Fed. Cir. December 15, 2023) -
In its only precedential patent decision last week, the Federal Circuit addressed both a claim construction issue and a procedural issue...more
Penumbra, Inc. v. Rapidpulse, Inc., IPR2021-01466, Paper 34 (P.T.A.B. March 10, 2023)
In a PTAB decision that was recently designated precedential, the Board made two important decisions concerning provisional patent...more
12/5/2023
/ America Invents Act ,
Claim Construction ,
Inter Partes Review (IPR) Proceeding ,
Inventions ,
Obviousness ,
Patent Applications ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art
In this week’s Case of Week, the Federal Circuit affirmed inter partes review decisions upholding as patentable Teleflex’s challenged patent claims directed to a method for use of a guide extension catheter in arteries. This...more
In re PersonalWeb Technologies LLC, Appeals Nos. 2021-1858, -1859, -1860 (Fed. Cir. Nov. 3, 2023)
In this appeal from the United States District Court for the Northern District of California, the question before the...more
11/7/2023
/ Ambiguous ,
Appeals ,
Attorney's Fees ,
Claim Construction ,
Exceptional Case ,
Multidistrict Litigation ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Remand ,
Vacated
Netflix, Inc. v. DivX, LLC, Appeal Nos. 2022-1203, -1204 (Fed. Cir. Oct. 25, 2023)
In its only precedential patent opinion this week, the Federal Circuit issued a cautionary note to petitioners in inter partes reviews. ...more
Cyntec Company, Ltd. v. Chilisin Electronics Corp., Appeal No. 2022-1873 (Fed. Cir. Oct. 16, 2023)
In this week’s Case of the Week, the Federal Circuit reversed and remanded a California district court’s judgment as a...more
10/24/2023
/ Appeals ,
Claim Construction ,
Damages ,
Daubert Standards ,
Expert Testimony ,
Inter Partes Review (IPR) Proceeding ,
Judgment As A Matter Of Law ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Remand ,
Vacated